Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective: A Markov Model
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI